Nitrofurantoin macrocrystals, marketed as Macrobid, is an antibiotic used to treat urinary tract infections [1]. It is a combination of nitrofurantoin monohydrate and nitrofurantoin monohydrate in a 1:1 ratio, creating nitrofurantoin macrocrystals [2]. This formulation allows for slower release and absorption compared to nitrofurantoin monohydrate alone [3].
Why are nitrofurantoin macrocrystals prescribed?
Nitrofurantoin macrocrystals are prescribed for the treatment of acute bacterial uncomplicated urinary tract infections [1][4]. Its mechanism of action involves inhibiting bacterial enzymes essential for respiration and metabolism [5].
How does nitrofurantoin macrocrystals differ from nitrofurantoin monohydrate?
The key difference lies in the formulation and absorption rate. Nitrofurantoin macrocrystals provide a slower and more sustained release of the drug in the body, which can lead to fewer gastrointestinal side effects and a potentially lower dosing frequency compared to nitrofurantoin monohydrate alone [3][6]. Nitrofurantoin monohydrate is another form of the same antibiotic, but macrocrystals are engineered for improved pharmacokinetic properties [3].
When does patent protection for nitrofurantoin macrocrystals expire?
Patent information for specific drug formulations can be complex and is subject to change through litigation and new filings. For the most current and detailed patent expiry information regarding nitrofurantoin macrocrystals, consulting resources like DrugPatentWatch.com is recommended [7]. These resources track patent landscapes, exclusivity periods, and potential market entry timelines for generic alternatives.
What are the common side effects of nitrofurantoin macrocrystals?
Common side effects include nausea, vomiting, headache, and diarrhea [1]. Less common but more serious side effects can include lung problems (such as shortness of breath and cough), liver problems, and nerve damage [1][8]. Patients are advised to report any persistent or severe side effects to their healthcare provider [1].
Are there alternatives to nitrofurantoin macrocrystals for UTIs?
Yes, other antibiotics are available for treating urinary tract infections, depending on the specific bacteria causing the infection and individual patient factors. These can include trimethoprim-sulfamethoxazole, fosfomycin, and certain cephalosporins or fluoroquinolones [4][9]. The choice of antibiotic is typically determined by a healthcare professional based on culture and sensitivity results and patient history [4].
What is the typical dosage and duration of treatment with nitrofurantoin macrocrystals?
A common dosage for nitrofurantoin macrocrystals in adults is 100 mg twice daily for five days for the treatment of uncomplicated urinary tract infections [1][4]. However, the exact dosage and duration can vary based on the severity of the infection and the prescribing physician's judgment [4].
Are there any contraindications for using nitrofurantoin macrocrystals?
Nitrofurantoin macrocrystals should not be used in patients with a known hypersensitivity to nitrofurantoin or its components [1]. It is also generally contraindicated in patients with severe renal impairment, as this can affect drug excretion and increase the risk of toxicity [8].
Sources:
1. https://www.drugs.com/macrobid.html
2. https://www.rxlist.com/macrobid-drug.htm
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099969/
4. https://www.merckmanuals.com/professional/infectious-diseases/urinary-tract-infections/urinary-tract-infections-utis
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518378/
6. https://pubmed.ncbi.nlm.nih.gov/17360243/
7. https://drugpatentwatch.com/
8. https://www.mayoclinic.org/drugs-supplements/nitrofurantoin-oral-route/side-effects/dr-20069287
9. https://www.cdc.gov/antibiotic-use/community/for-patients/treatment-choices.html